What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health?

Archives of Disease in Childhood

Volumn 95, Issue 4, 2010, Pages 256-261

  Ford, Anna L ^a,b   Hunt, Linda P ^a,b   Cooper, Ashley ^a   Shield, Julian P H ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY FAT; BODY MASS; BODY MASS INDEX SD SCORE; CHILD; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; FEMALE; GLUCOSE METABOLISM; HUMAN; IMPEDANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLISM; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; WAIST CIRCUMFERENCE;

ADOLESCENT; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; OBESITY; WEIGHT LOSS;

EID: 77950307539     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.165340     Document Type: Article

References (28)

1. Jackson-Leach R, Lobstein T. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 1. The increase in the prevalence of child obesity in Europe is itself increasing. Int J Pediatr Obes 2006;1:26-32.
2. Lobstein T, Jackson-Leach R. Child overweight and obesity in the USA: prevalence rates according to IOTF definitions. Int J Pediatr Obes 2007;2:62-64
3. Klein S, Burke LE, Bray GA, et al.. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004;110:2952-2967
4. Freedman DS, Dietz WH, Tang R, et al. The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2004;28:159-166
5. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 2002;51:204-209
6. Lobstein T, Jackson-Leach R. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes 2006;1:33-41.
7. Reinehr T, de Sousa G, Toschke AM, et al. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr 2006;84:490-496
8. Sabin MA, Ford A, Hunt L, et al. Which factors are associated with a successful outcome in a weight management programme for obese children? J Eval Clin Pract 2007;13:364-368
9. Bergh CSM, Shield J, Hellers G, et al. A framework for the treatment of obesity: early support. In: Blass E, ed. Obesity: causes, mechanisms, and prevention. Sunderland, Massachusetts, USA: Sinauer Associates Inc, 2008:399-425.
10. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995;73:25-29
11. Cole TJ, Faith MS, Pietrobelli A, et al. What is the best measure of adiposity change in growing children: BMI, BMI %, BMI z-score or BMI centile? Eur J Clin Nutr 2005;59:419-425
12. Roberts K, Cavill N, Rutter H. Standard Evaluation Framework for weight management interventions: National Obesity Observatory, 2009.
13. O'Brien E, Petrie J, Littler W, et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993;11:677-679
14. Sobey WJ, Beer SF, Carrington CA, et al. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 1989;260:535-541
15. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and â-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419
16. Sabin MA, Hunt LP, Ford AL, et al. Elevated glucose concentrations during an oral glucose tolerance test are associated with the presence of metabolic syndrome in childhood obesity. Diabet Med 2008;25:289-295
17. Pietrobelli A, Rubiano F, St-Onge MP, et al. New bioimpedance analysis system: improved phenotyping with whole-body analysis. Eur J Clin Nutr 2004;58:1479-1484
18. Pietrobelli A, Malavolti M, Fuiano N, et al. The invisible fat. Acta Paediatr Suppl 2007;96:35-38
19. Pietrobelli A, Tatò L. Body composition measurements: from the past to the future. Acta Paediatr Suppl 2005;94:8-13.
20. McCarthy HD, Cole TJ, Fry T, et al. Body fat reference curves for children. London: Int J Obes 2006;30:598-602.
21. Tanner JM. Normal growth and techniques of growth assessment. Clin Endocrinol Metab 1986;15:411-451
22. Hunt LP, Ford A, Sabin MA, et al. Clinical measures of adiposity and percentage fat loss: which measure most accurately reflects fat loss and what should we aim for? Arch Dis Child 2007;92:399-403.
23. Reinehr T, Kiess W, Kapellen T, et al. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 2004;114:1569-1573
24. Reinehr T Andler W. Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child 2004;89:419-422
25. Reinehr T, Stoffel-Wagner B, Roth CL, et al. High-sensitive C-reactive protein, tumor necrosis factor á, and cardiovascular risk factors before and after weight loss in obese children. Metabolism 2005;54:1155-1161.
26. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 2001;323:1123-1124
27. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004;29:439-493
28. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334